Biobin 500 mg/5 ml Injection 5 ml is an anticancer medicine used in the treatment of leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. Biobin 500 mg/5 ml Injection 5 ml is used in the treatment of different types of leukemias, such as acute non-lymphocytic leukemia, acute lymphocytic leukemia, chronic myelocytic leukemia and meningeal leukemia.

Biobin 500 mg/5 ml Injection 5 ml contains Cytarabine, which belongs to the class of antimetabolites. It works by inhibiting the DNA polymerase enzyme responsible for DNA elongation, synthesis, and repair. In general, it inhibits the production of genetic material (DNA) in the cancer cells that are essential for the growth, repair and multiplication of cells. Thus, Biobin 500 mg/5 ml Injection 5 ml stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.

Biobin 500 mg/5 ml Injection 5 ml may cause certain side effects such as vomiting, nausea, mouth ulcers, loss of appetite, diarrhea, dark-coloured urine, stomach pain, hair loss, dizziness, weakness, and pain at the site of injection, prescribed by your doctor. Most of these side effects of Biobin 500 mg/5 ml Injection 5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please seek medical help. A trained healthcare professional will administer Biobin 500 mg/5 ml Injection 5 ml. Hence, do not self-administer.

If you are allergic to Biobin 500 mg/5 ml Injection 5 ml, inform your doctor and avoid taking it. Inform your doctor about your complete medical and medication history before starting treatment with Biobin 500 mg/5 ml Injection 5 ml. Biobin 500 mg/5 ml Injection 5 ml is contraindicated for pregnant women and breastfeeding women due to serious embryo-fetal toxicity. Hence, inform your doctor if you are pregnant, planning to become pregnant or breastfeeding. Inform your doctor if you have/had kidney or liver disease. Avoid alcohol consumption with Biobin 500 mg/5 ml Injection 5 ml as it may increase the risk of liver damage. Avoid excessive exposure to sunlight as Biobin 500 mg/5 ml Injection 5 ml may cause sensitivity to sunlight. You are advised to use sunscreen and wear protective clothing while going out.

Biobin 500 mg/5 ml Injection 5 ml contains Cytarabine, which belongs to the class of antimetabolites. It works by inhibiting the DNA polymerase enzyme that is responsible for DNA elongation, synthesis, and repair. In general, it inhibits the production of genetic material (DNA) in the cancer cells that are essential for cell growth, repair and multiplication. Thus, Biobin 500 mg/5 ml Injection 5 ml stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.

Biobin 500 mg/5 ml Injection 5 ml should be avoided if you are allergic to it or any other component present in it. Inform your doctor about your complete medical and medication history before starting treatment with Biobin 500 mg/5 ml Injection 5 ml. Biobin 500 mg/5 ml Injection 5 ml is contraindicated for pregnant women and breastfeeding women due to serious embryo-fetal toxicity. Hence, inform your doctor if you are pregnant, planning to become pregnant or breastfeeding. Inform your doctor if you have/had any pre-existing liver or kidney disease. Avoid taking Biobin 500 mg/5 ml Injection 5 ml if you are pregnant, as it may harm the foetus. Avoid alcohol consumption with Biobin 500 mg/5 ml Injection 5 ml as it may increase the risk of liver damage. Avoid excessive exposure to sunlight as Biobin 500 mg/5 ml Injection 5 ml may cause sensitivity to sunlight. You are advised to use sunscreen and wear protective clothing while going out. If you are about to receive any vaccinations, inform your doctor that you are taking Biobin 500 mg/5 ml Injection 5 ml as it may cause infection.

• Regular blood tests are recommended while taking Biobin 500 mg/5 ml Injection 5 ml to monitor the number and type of cells in the blood. 
• Biobin 500 mg/5 ml Injection 5 ml, like other cytotoxic medicines, can cause hyperuricemia due to the fast lysis of neoplastic cells. Blood uric acid levels should be monitored and be ready to utilize any supportive or pharmacologic interventions that may be required to address this condition.